MTCR — Metacrine Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $25.48m
- -$13.48m
Annual cashflow statement for Metacrine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.3 | -25.8 | -28.9 | -37.3 | -62.2 |
| Depreciation | |||||
| Non-Cash Items | 0.643 | 1.11 | 1.95 | 6.04 | 8.31 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.4 | -1.03 | -1.02 | -5.26 | 6.44 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -10.1 | -25.5 | -27.7 | -36.2 | -47.2 |
| Capital Expenditures | -0.42 | -0.69 | -0.084 | -0.206 | -0.008 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -56.5 | 17.8 | -31.9 | 43.9 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.42 | -57.2 | 17.7 | -32.1 | 43.9 |
| Financing Cash Flow Items | — | 0 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 22.3 | 64.8 | 9.75 | 77 | 27.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.8 | -17.9 | -0.297 | 8.72 | 24.5 |